HCM
GSK icon

Huber Capital Management’s GSK GSK Stock Holding History

Huber Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$680K Sell
12,329
-80
-0.6% -$4.33K 0.11% 74
2025
Q4 		$609K Hold
12,409
– – 0.09% 90
2025
Q3 		$536K Hold
12,409
– – 0.08% 94
2025
Q2 		$477K Buy
12,409
+5,480
+79% +$209K 0.08% 95
2025
Q1 		$268K Hold
6,929
– – 0.05% 103
2024
Q4 		$234K Buy
6,929
+2,001
+41% +$72K 0.05% 104
2024
Q3 		$201K Buy
+4,928
New +$202K 0.04% 99
2024
Q2 		– Sell
-25,692
Closed -$1.1M – 97
2024
Q1 		$1.1M Sell
25,692
-29
-0.1% -$1.2K 0.25% 71
2023
Q4 		$953K Sell
25,721
-29,671
-54% -$1.07M 0.24% 76
2023
Q3 		$2.01M Sell
55,392
-20,311
-27% -$721K 0.47% 53
2023
Q2 		$2.7M Hold
75,703
– – 0.65% 45
2023
Q1 		$2.69M Buy
75,703
+27,031
+56% +$946K 0.67% 46
2022
Q4 		$1.71M Buy
48,672
+23,599
+94% +$786K 0.43% 52
2022
Q3 		$738K Buy
25,073
+39
+0.2% +$1.48K 0.21% 65
2022
Q2 		$1.36M Sell
25,034
-3,600
-13% -$199K 0.38% 52
2022
Q1 		$1.56M Sell
28,634
-1,600
-5% -$86.9K 0.39% 56
2021
Q4 		$1.67M Sell
30,234
-2,966
-9% -$154K 0.44% 50
2021
Q3 		$1.59M Sell
33,200
-800
-2% -$40.2K 0.41% 53
2021
Q2 		$1.69M Sell
34,000
-800
-2% -$38.4K 0.43% 56
2021
Q1 		$1.55M Sell
34,800
-2,880
-8% -$131K 0.42% 53
2020
Q4 		$1.73M Buy
37,680
+2,880
+8% +$132K 0.57% 49
2020
Q3 		$1.64M Sell
34,800
-106,080
-75% -$5.31M 0.6% 44
2020
Q2 		$7.18M Sell
140,880
-10,400
-7% -$534K 1.47% 24
2020
Q1 		$7.17M Hold
151,280
– – 1.31% 26
2019
Q4 		$8.89M Sell
151,280
-29,840
-16% -$1.66M 1.17% 29
2019
Q3 		$9.66M Sell
181,120
-19,200
-10% -$988K 1.2% 29
2019
Q2 		$10M Sell
200,320
-40,080
-17% -$2.01M 1.19% 31
2019
Q1 		$12.6M Buy
+240,400
New +$12M 1.33% 30

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Huber Capital Management's GSK Position: Q1 2026 in Review

Huber Capital Management reduced its GSK (GSK) stake by 0.64% in Q1 2026, selling an estimated $4.33K and leaving 12,329 shares worth $680K. The position accounts for 0.11% of the portfolio, ranked #74.

Huber Capital Management first reported a position in GSK in Q1 2019 and has held it in 28 quarters since. The position peaked at $12.6M in Q1 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Huber Capital Management held 12,329 shares of GSK worth $680K as of Q1 2026.
  • Huber Capital Management sold 80 GSK shares in Q1 2026, an estimated $4.33K.
  • GSK made up 0.11% of Huber Capital Management's portfolio in Q1 2026, its #74 holding.
  • Huber Capital Management first reported a position in GSK in Q1 2019 and has held it in 28 quarters since.
  • Huber Capital Management's GSK position peaked at $12.6M in Q1 2019.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Huber Capital Management's 13F filing for Q1 2026, filed 12 May 2026.